'Banned' Cilic denies 'faking injury to disguise failed drug test' allegations

Image
ANI Johannesburg
Last Updated : Sep 26 2013 | 8:40 AM IST

Croatian tennis player Marin Cilic has reportedly denied allegations by the International Tennis Federation (ITF) that he had pulled out of this year's Wimbledon Championships by faking a knee injury to disguise a failed drug test.

Cilic was banned for nine months for testing positive for banned supplement nikethamide after taking Coramine glucose tablets purchased at a pharmacy in Monte Carlo.

Stating that he wanted to address 'certain media reports' which suggested that he had 'feigned' an injury at Wimbledon, Cilic said that he had already developed a significant knee injury before Wimbledon, which got aggravated during his first round match.

However, Cilic insisted that although he was very keen to continue playing at Wimbledon, he was advised that there was a possibility that his Wimbledon results could be wiped out depending on the result of his case.

According to Cilic, it did not make any sense for him to risk causing his knee a more severe injury and to deprive other players the opportunity of playing further into the tournament, following which he decided to pull out of Wimbledon and accept a voluntary suspension pending the determination of his case.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Sep 26 2013 | 8:38 AM IST

Next Story